Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial - Concepedia

Concepedia

Publication | Open Access

Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

DOI Full Paper Access

333

Citations

24

References

2014

Year

Eitan Kerem, Michael W. Konstan, K. De Boeck, Frank J. Accurso, Isabelle Sermet‐Gaudelus, Michael Wilschanski, J.S. Elborn, Paola Melotti, Inez Bronsveld, Isabelle Fajac,

The Lancet Respiratory Medicine

AllergyPlacebo-controlled Phase 3Clinical TrialsNonsense-mutation Cystic FibrosisMedicineMolecular Medicine

References

	Year	Citations

Page 1